Vaxxinity, Inc. VAXX
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $15.5M
- P/E
- 0.0×
Follow VAXX
| Older periods | Mar '23 | Jun '23 | Sep '23 | Dec '23 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.56 | 2.36 | 1.98 | 1.73 | |
Current Ratio |
2.77 | 2.51 | 2.15 | 1.89 | |
Net Debt/EBITDA |
2.95 | 3.05 | 2.34 | 1.50 | |
Debt/Assets |
14.84% | 17.29% | 20.84% | 29.93% | |
Debt/Equity |
0.28 | 0.35 | 0.51 | 0.99 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.09 | 0.87 | 1.00 | 1.04 | |
Capex/Depreciation |
(0.89) | (1.23) | (0.39) | (3.04) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.16) | (0.10) | (0.10) | (0.09) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.16) | (0.10) | (0.10) | (0.10) | |
Cash per Share |
0.54 | 0.44 | 0.34 | 0.24 | |
Shareholders Equity per Share |
0.37 | 0.28 | 0.19 | 0.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.37 | 0.28 | 0.19 | 0.11 | |
Free Cash Flow |
(20.22) | (12.25) | (13.31) | (12.26) | |
Working Capital |
46.97 | 35.93 | 24.80 | 15.63 | |
Capital Expenditures |
(0.17) | (0.09) | (0.13) | (0.41) | |
Net Current Asset Value |
34.04 | 23.35 | 12.58 | 2.33 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.46 | 0.40 | 0.40 | — | |
Average Payables |
2.24 | 1.12 | 3.15 | 3.54 | |
Average Assets |
116.53 | 104.18 | 90.22 | 75.36 | |
Average Common Equity |
79.39 | 66.18 | 51.98 | 37.79 |
Columns are period end dates